Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD



Rating:

Share or cite this content

Citations should be made in the following way:
Emanuela Cova (Pavia, Italy), Emanuela Cova, Gabriele Ceccarelli, Laura Pandolfi, Manuela Agozzino, Raffaele Allevi, Laura Benedetti, Miriam Colombo, Simona Inghilleri, Sara Magni, Tiberio Oggionni, Davide Prosperi, Maria Gabriella Cusella, Federica Meloni. Engineered gold nanoparticles targeted to mesenchymal cells from BOS patients can be safely administered to normal mice by inhalation. Eur Respir J 2015; 46: Suppl. 59, 1793

Member's Comments

No comment yet.

Related content which might interest you: Biodistribution of engineered hematite nanoparticles in healthy and asthmatic mice Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Intratracheal administration of dry powdered low-molecular-weight chitosan/siRNA complexes suppressed gene expression in the airway, alveoli, and metastatic tumors in murine lung Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Effect of low level laser (LLL) and mesenchymal stem cells (htMSCs) therapies on cigarette-induced lung inflammation in mice Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 Exogenous administration of bone marrow-derived stem cells in experimental COPD Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 Pretreatment of human adipose derived mesenchymal stem cells with PPAR-γ agonist improved effects of regeneration in elastase induced emphysema mouse model Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Evaluation of nanoparticles in human lung fibroblasts and PCLS Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Genetic influence on inflammatory response in rats exposed to nanosized titanium dioxide particles Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Determinants of inflammatory and functional toxicity of silver nanospheres in rat lung Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 Deposition and pulmonary effect of nanoparticle in whole body inhalation study and in nose only inhalation study Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Tissue distribution of inhalation drugs in rat lung slices Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Synergistic effect of human tubal mesenchymal stem cell (htMSCs) and low level laser (LLL) therapy significantly reduces experimental COPD in mice Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Gene expression profile of pulmonary inflammation in rat lung induced by nickel oxide nanoparticles following intratracheal instillation Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 Morphological changes in the lungs of rats after xenogeneic transplantation of lymphocytes of asthma patients Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Immunosuppressive properties of bronchial epithelial cells are altered in lung transplant recipients: “ex-vivo” model of T cell-allogeneic response Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction Year: 2013 Comparing the effects of orally and intranasally administered IKK2 inhibitors in a 4 day tobacco-smoke exposed model of COPD Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 Effects of diesel exhausted particles on lung inflammation in OVA-sensitized and single challenged mice Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Intratracheal application of healthy lung derived Mesenchymal Stem Cells (DON-MSC) in the form of biospheres (BS) as potential therapeutic agents for chronic lung disease Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Comparative effects of inhaled and intravenous mesenchymal stem cells in bleomycin-induced pulmonary fibrosis in rabbits Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015